Ur Metser

200 Elizabeth St, M5G, 2C4
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 184 publications

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Journal: Frontiers in oncology

Published: June 22, 2026

Diagnostic and Prognostic Value of Hypoxia PET in Glioma: A Systematic Review and Meta-Analysis.

Diagnostic and Prognostic Value of Hypoxia PET in Glioma: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: May 12, 2026

Correction: Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma.

Correction: Prospective study on 18F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma.

Journal: British journal of cancer

Published: April 15, 2026

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: March 13, 2026

Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.

Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 29, 2026

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Journal: Scientific reports

Published: January 28, 2026

Late recurrent renal cell carcinoma presenting as a solitary gallium-68 DOTATATE-avid pancreatic mass with polycythemia.

Late recurrent renal cell carcinoma presenting as a solitary gallium-68 DOTATATE-avid pancreatic mass with polycythemia.

Journal: JCEM case reports

Published: December 04, 2025

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Journal: Hematological oncology

Published: November 03, 2025

The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis.

The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis.

Journal: Clinical nuclear medicine

Published: October 30, 2025

Patterns and Predictors of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Detected Local Recurrence Following Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

Patterns and Predictors of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Detected Local Recurrence Following Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 13, 2025

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium.

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium.

Journal: European journal of human genetics : EJHG

Published: September 30, 2025

Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer.

Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer.

Journal: Cancers

Published: September 23, 2025

Showing 1-12 of 184

Last Updated: 09/26/2026